BLUE BELL, Pa., March 29, 2011 /PRNewswire/ — Inovio
Pharmaceuticals, Inc. (NYSE Amex:
INO), a leader in the development of therapeutic and preventive
vaccines against cancers and infectious diseases, announced today
that the company will make presentations at two scientific
conferences:Immunopotentiators in Modern VaccinesPorto, Portugal,
April 6-8, 2011Tiara Park Atlantico HotelInovio
PresentationAmir Khan, Ph.D., Director of Product
DevelopmentApril 7, 2011Session 8″Development of molecular
adjuvants for DNA vaccines”http://www.meetingsmanagement.com/imv_2011/index.htmWorld
Vaccine CongressWashington, D.C., April 11-14, 2011Gaylord National
Hotel and Convention CenterInovio PresentationsNiranjan
Sardesai, Ph.D., Sr. VP, Research and Development April 12,
20112:10pm Stream B
Designing DNA-based vaccines with the capability to provide
universal protection against unmatched influenza virus
strainsApril 12, 20115:50pm Stream B
Panel session: Universal influenza vaccine: what challenges must be
overcome to ensure feasibility?April 13, 20113:25pm Stream A
Panel session: Funding and reimbursement: a new dealmaking
hurdle?
http://www.terrapinn.com/conference/world-vaccine-congress-washington/About
Inovio Pharmaceuticals, Inc.Inovio is developing a new generation
of vaccines, called DNA
‘/>”/>
SOURCE
